Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
3.7K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

4.6K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.6K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

152
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
152
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

930
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
930
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

8.1K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.1K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

159
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrinsically chiral exciton polaritons in an atomically-thin semiconductor.

Nature communications·2026
Same author

Structural studies of calcium silicate hydrate modified with heavy metal cations.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2024
Same author

Effect of compaction on bisulfide diffusive transport through MX-80 bentonite.

Journal of contaminant hydrology·2024
Same author

Targeted therapies for glioblastoma treatment.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data.

BMC pulmonary medicine·2023
Same author

Orbital Cavernous Venous Malformation in a 35-Year-Old Man: A Case Report.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2023

Related Experiment Video

Updated: Dec 31, 2025

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.9K

Exploiting iron-binding proteins for drug delivery.

M Bialasek1, M Kubiak1, M Gorczak1

  • 1Department of Cancer Biology, Institute of Biology, Warsaw University of Life Sciences - SGGW, Warsaw, Poland.

Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|January 1, 2020
PubMed
Summary
This summary is machine-generated.

Iron-binding proteins like transferrin, ferritin, and hemoglobin show promise for targeted drug delivery, overcoming therapy failures caused by low drug concentration and systemic toxicity in diseases including cancer.

More Related Videos

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

825
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

9.2K

Related Experiment Videos

Last Updated: Dec 31, 2025

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.9K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

825
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

9.2K

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Molecular Biology

Background:

  • Many therapies fail due to insufficient drug dose at the target site and high systemic toxicity.
  • Protein-based drug delivery systems offer potential for increased drug concentration and targeted delivery, especially to malignant cells.
  • Iron is essential in many disorders, including various cancers, creating a need for effective iron-related therapies.

Purpose of the Study:

  • To review the characteristics of human iron-binding proteins.
  • To present the application of iron-binding proteins as drug carriers in targeted drug delivery strategies.

Main Methods:

  • Literature review of scientific articles on iron-binding proteins and drug delivery.
  • Analysis of the properties of transferrin, ferritin, and hemoglobin as drug carriers.
  • Summary of current targeted drug delivery strategies utilizing these proteins.

Main Results:

  • Human iron-binding proteins (transferrin, ferritin, hemoglobin) possess characteristics suitable for drug delivery.
  • These proteins can be engineered or utilized to increase drug concentration at specific sites or target cancer cells.
  • Existing research demonstrates the potential of these proteins in various targeted drug delivery applications.

Conclusions:

  • Iron-binding proteins represent a promising platform for developing advanced drug delivery systems.
  • Targeted delivery using these proteins can potentially improve therapeutic efficacy and reduce systemic toxicity.
  • Further research into optimizing these protein-based carriers is warranted for clinical translation.